Implementation of therapeutic hypothermia after cardiac arrest in intensive care units in Poland by Krawczyk, Paweł et al.
www.kardiologiapolska.pl
Kardiologia Polska 2013; 71, 3: 270–274; DOI: 10.5603/KP.2013.0040 ISSN 0022–9032
ARTYKUŁ ORYGINALNY / ORIGINAL ARTICLE
Implementation of therapeutic hypothermia after 
cardiac arrest in intensive care units in Poland
Paweł Krawczyk, Gabriela Kołodziej, Bartłomiej Szpyra, Janusz Andres
Department of Anaesthesiology and Intensive Care, Jagiellonian University Medical College, Cracow, Poland
A b s t r a c t
Background: Therapeutic hypothermia (TH) is one of few interventions that improve survival after a cardiac arrest with good 
neurological outcome. Current guidelines for cardiopulmonary resuscitation recommend TH in comatose adult patients after 
return of spontaneous circulation (ROSC) regardless of cardiac arrest location and cardiac rhythm during the event. 
Aim: To evaluate level of TH implementation in intensive care units (ICUs) in Poland and identify barriers to the implementa-
tion process. 
Methods: A telephone survey was carried out to determine how many Polish ICUs were using TH in the management of 
comatose patients after a cardiac arrest. The survey was conducted from October to December 2010. The survey also in-
cluded questions on the number of patients cooled, method of TH induction and maintenance, target temperature, duration 
of cooling, and cardiac arrest rhythm in patients treated with TH. We have also collected data on pre-hospital use of TH and 
potential barriers to implementation of TH. 
Results: We obtained information from 263 of 464 ICUs (56.8%) in Poland. At the time of the survey, 57 ICUs (21.7%) were 
using TH in comatose patients after ROSC. There was a significant increase in the number of ICUs using TH as compared 
with the 2005 survey. Most ICUs did not use any sophisticated equipment to induce and maintain TH. Ninety six percent of 
ICUs were using TH regardless of the cardiac arrest rhythm. In 65% of ICUs (37 units), target temperature was 32–34°C and 
63% of ICUs (36 units) maintained TH for 12–24 hours. An increase in ICU experience in TH can be noted: 61% of ICUs 
(35 units) declared TH use in more than 10 patients during the last year. We found the following barriers to implementation 
of TH: lack of knowledge, lack of local protocols, lack of equipment, and economic issues. 
Conclusions: The number of ICUs using TH in Poland increased threefold in the 5 year period of 2005–2010. However, the 
proportion of ICUs using TH is still low (21.7%) compared to other European countries. Further efforts should be undertaken 
to reduce barriers to implementation of current resuscitation guidelines.
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INTRODUCTION
Therapeutic hypothermia (TH), defined as controlled lower-
ing of core body temperature to 32–34°C for 12–24 hours, 
is one of few interventions that improve survival after cardiac 
arrest with good neurological outcome [1]. Improvement of 
outcomes in patients who suffered a cardiac arrest requires 
practical application of scientific knowledge on resuscitation, 
which is possible when adequate education and implementa-
tion strategies are used [2]. Current resuscitation guidelines 
recommend TH in patients after a cardiac arrest (regardless 
of its rhythm or location) who remain comatose (no reaction 
to verbal stimulation) after return of spontaneous circulation 
(ROSC) [1] but TH is still not considered a standard therapeutic 
procedure in many countries.
A survey on the use of TH in intensive care units (ICUs) 
in Poland conducted in 2005 showed that only 7.6% of these 
units used this therapeutic approach in patients after a cardiac 
arrest [3]. Recent data on the use of TH show a wide variation 
in the proportion of treated patients [4–6]. As no data are 
available on the current degree of guideline implementation 
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regarding the use of TH in ICUs in Poland, we attempted to 
fill this gap in knowledge.
METHODS
From October to December 2010, a telephone survey was 
carried out in ICUs in Poland, using a database available to 
the national consultant in anaesthesiology and intensive care. 
The surveyed ICUs were run by specialists in anaesthesiology 
and intensive care and cared for both adult and paediatric 
patients. The purpose of the survey was to determine how 
many Polish ICUs were using TH in the management of co-
matose patients after cardiac arrest and subsequent ROSC. 
The questionnaire included 9 items: 
1. Do you use TH in your unit?
2. How many patients did you cool during the last year?
3. What methods do you use to induce and maintain TH?
4. What is the target temperature?
5. What is the duration of TH?
6. What rhythms of cardiac arrest do you consider when 
selecting patients for TH?
7. Do you use pre-hospital TH?
8. If you do not use TH, do you plan to implement this treat-
ment?
9. If you do not use TH, what are the reasons for this?
The survey was supposed to be answered by chief ICU 
physicians, and if those were not available, by other physicians 
working in the ICU. 
RESULTS
Using a database available to the national consultant in an-
aesthesiology and intensive care, we were able to contact by 
phone 363 of 464 ICUs in Poland. Data on the use of TH 
after cardiac arrest were obtained from 263 ICUs (56.8% of 
all units). Reasons for lacking data from the remaining ICUs 
included inability to contact a given unit by phone (despite 
repeated attempts), inability to obtain information due to lack 
of appropriately informed or authorised healthcare person-
nel, lack of consent, and lack of willingness to participate in 
a telephone survey. If an attempt to contact a unit and obtain 
information on the use of TH was successful, all required 
data were collected in all cases. The use of TH was reported 
by 57 ICUs (21.7%) of the surveyed units. Figure 1 shows an 
administrative map of Poland with voivodeships and numbers 
of ICUs using TH in each voivodeship.
Comparison of the current survey results with those of 
a 2005 survey [3] showed a threefold increase in the propor-
tion of ICUs using TH (7.6% vs. 21.7%). Other results of the 
survey are shown in Table 1.
Most units reporting the use of TH (84%) cooled more 
than 5 patients during the last year. External (noninvasive) 
methods were primarily used, most commonly (60%) cold 
packing with ice packs or cooled gels. Five ICUs used dedi-
cated equipment for noninvasive TH including cooling gel 
mats or body wraps and cool caps. Other external cooling 
methods (13 units — 18.5%) included cold head packs and 
cooling with fans to induce air flow around the patient with 
additional skin moisturising to enhance cooling by water 
evaporation. Intravenous infusions of cold fluids were used 
in only 8.5% of cases, and other internal cooling methods 
including stomach or bladder washing with cold fluids were 
used in 6% of patients. Target temperature was 32–34°C in 
65% of ICUs, 63% units used TH for 12–24 hours, and 26% 
units used TH for more than 24 hours. Nearly all ICUs used 
TH regardless of the cardiac arrest rhythm. Prehospital TH 
was used in 4% of units.
Seventy of 206 ICUs not using TH planned to implement 
this treatment method in patients after cardiac arrest. The 
most commonly reported reasons for not using TH included 
lack of knowledge, experience, local protocols, specialised 
equipment, or financial limitations, e.g. lack of reimbursement 
of expenses related to the use of this therapeutic approach.
DISCUSSION
Our findings indicate nearly threefold increase in the use of TH 
by ICUs in Poland during 5 years. However, still only 21.7% 
Figure 1. Location and number of intensive care units using 
therapeutic hypothermia after cardiac arrest. Voivodeships:  
DŚ — Lower Silesian (dolnośląskie); KP — Kuyavian-Pomera-
nian (kujawsko-pomorskie); LB — Lublin (lubelskie); LU —  
Lubusz (lubuskie); ŁD — Łódź (łódzkie); MŁ — Lesser Poland 
(małopolskie); MZ — Masovian (mazowieckie); OP — Opole 
(opolskie); PK — Subcarpathian (podkarpackie); PM — Pome-
ranian (pomorskie); PO — Podlaskie (podlaskie); ŚL — Silesian 
(śląskie); ŚW — Świętokrzyskie (świętokrzyskie); WM — War-
mian-Masurian (warmińsko-mazurskie); WP — Greater Poland 
(wielkopolskie); ZP — West Pomeranian (zachodniopomorskie)
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(36 units) used TH for 12–24 hours. Survey results show that 
26% of ICUs (15 units) use TH for more than 24 hours. Cur-
rently available data do not suggest any benefits of extended 
duration of TH in adult patients after cardiac arrest and sub-
sequent ROSC, although the optimal duration of TH has not 
been clearly defined [7].
Experience of Polish centres with this treatment approach 
is increasing. More than 10 patients were cooled during the 
last year in 61% of ICUs (35 units) using TH. A vast majority 
of units do not use any dedicated TH equipment. A major 
limitation reported by the surveyed centres is the financial 
aspect, i.e. higher costs of TH using dedicated equipment. 
Currently available literature data do not indicate better 
outcome of TH using dedicated equipment but the use of 
the latter is associated with significant advantages in terms of 
improved temperature stability and decreased workload of 
the healthcare personnel [1, 8].
The most commonly used approach to TH in ICUs in 
Poland involved cold packing with ice packs or cooled gels, 
and the use of fans to induce air flow around the patient. 
Cold crystalloid infusion was used to induce TH in only 8.5% 
of cases. The 2010 resuscitation guidelines recommend TH 
induction with intravenous infusion of 30 mL/kg of crystal-
loids cooled to 4°C. This results in a rapid lowering of core 
body temperature by 1.6°C [1, 9] and helps achieve the target 
temperature faster without any significant adverse effects.
Results of our survey indicate that TH is rarely initiated in 
the prehospital phase. Report on the use of TH in humans do 
not suggest any significant benefits of early implementation 
of TH, and a time window of 4 hours has been proposed. 
Animal models showed improved neurological outcome and 
increased rate of ROSC with earlier implementation of TH, 
even during cardiac arrest [10, 11].
Data collected from those ICUs that did not use TH 
indicate that 34% of them (70 ICUs) plan to implement this 
therapeutic approach. Main reported barriers included lack 
of treatment protocols, knowledge and experience with this 
method. Respondents also reported barriers related to limited 
access to dedicated equipment, and problems with reimburse-
ment of expenses related to the use of TH. This is a major 
problem impending implementation of TH in patients after 
cardiac arrest, although inexpensive noninvasive protocols 
have been reported in the literature that allow effective institu-
tion of TH without the use of sophisticated equipment [12]. 
Numerous aspects of barriers to the implementation of 
TH have been discussed in the literature. Most commonly 
identified barriers include lack of awareness or knowledge of 
guidelines and clear evidence of benefits presented in these 
documents; lack of self-confidence and belief in the positive 
effects of intervention; therapeutic inertia; lack of detailed 
treatment protocols; and barriers related to interdisciplinary 
care of patients after cardiac arrest (emergency medicine, 
intensive care, nursing) [13].
Table 1. Results of the survey on the use of therapeutic hypo-
termia in intensive care units in Poland
Number of patients treated with TH 
during the last year
Proportion
1−5 16% (9/57)
6−10 23% (13/57)
11−20 17% (10/57)
> 20 44% (25/57)
Methods used to induce/maintain TH*
Internal
Cold intravenous fluids 8.5% (6/70)
Dedicated TH devices 0% (0/70)
Other (see text) 6% (4/70)
External
Cold packing (ice packs, cooled gels) 60% (42/70)
Dedicated TH devices 7% (5/70)
Other (see text) 18.5% (13/70)
Target temperature  
32–34oC 65% (37/57)
Other 35% (20/57)
Duration of TH  
12−24 h 63% (36/57)
> 24 h 26% (15/57)
< 12 h 11% (6/57)
Cardiac arrest rhythms in patients treated with TH 
Shockable rhythms only (VF/VT) 2% (1/57)
Non-shockable rhythms only  
(PEA/asystole)
2% (1/57)
All cardiac arrest rhythms 96% (55/57)
Prehospital TH use  
Yes 4% (2/57)
No 96% (55/57)
Planned implementation of TH  
(by units currently not using TH)
Yes 34% (70/206)
No 66% (136/206)
Reasons for not using TH
Lack of knowledge, experience, protocols 22% (45/206)
Lack of equipment, funding 22% (45/206)
Both 56% (116/206)
* Units could report more than 1 method; TH — therapeutic hypother-
mia; PEA — pulseless electrical activity; VF — ventricular fibrillation;  
VT — ventricular tachycardia
of surveyed ICUs use TH. Nearly all units using TH cooled 
patients regardless of cardiac arrest rhythms. In 65% of ICUs 
(37 unit), target temperature was 32–34oC, and 63% of ICUs 
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Literature data indicate that intensive education and im-
plementation programs may result in a significant improvement 
regarding the use of TH. For example, wide implementation of 
TH in the United Kingdom (an increase in the rate of TH use from 
28% to 85.6% of patients after cardiac arrest) took place within 
only about 5 years [4]. Improved implementation of TH may 
also be related with prehospital use of this treatment approach: 
in some areas of the Czech Republic, up to 70% of centres have 
been reported to initiate TH during prehospital phase [14].
The Czech experience also suggests that implementation 
of TH benefited from issuing a national consensus statement 
on TH, dissemination of ready-to-use TH protocols, and 
undertaking research projects related to TH. The rate of TH 
use was higher in units admitting more that 10 patients after 
a cardiac arrest annually [6, 14]. 
The major limitation of our study was inability to obtain 
information from all ICUs in Poland. We did not analyse TH 
use separately in paediatric patients. Importantly, patients after 
a cardiac arrest are also managed in intensive coronary care 
units and cardiac catheterisation laboratories, but data from 
these centres were not collected in our study.
CONCLUSIONS
Therapeutic hypothermia in comatose patients after cardiac 
arrest has not become a standard treatment used in ICUs in Po-
land. Identified barriers to guideline implementation include 
lack of knowledge, experience, local protocols, and national 
guidelines, as well as lack of reimbursement of costs of this 
therapy. Efforts to improve this situation should be targeted 
at comprehensive and interdisciplinary initiatives approved 
by recognised scientific societies and other advisory bodies.
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Implementacja hipotermii terapeutycznej  
po zatrzymaniu krążenia na oddziałach  
anestezjologii i intensywnej terapii w Polsce
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S t r e s z c z e n i e
Wstęp: Hipotermia terapeutyczna (TH) jest jedną z niewielu interwencji o udowodnionym wpływie na poprawę przeżycia 
z dobrym wynikiem neurologicznym leczenia u pacjentów po zatrzymaniu krążenia. Aktualne wytyczne resuscytacji krąże-
niowo-oddechowej zalecają kontrolę temperatury i zastosowanie TH u dorosłych pacjentów pozostających w stanie śpiączki 
po zatrzymaniu krążenia, niezależnie od jego mechanizmu i lokalizacji. 
Cel: Celem pracy była ocena stanu implementacji TH po zatrzymaniu krążenia na polskich oddziałach anestezjologii i inten-
sywnej terapii (OAIT) i próba identyfikacji ograniczeń w implementacji wytycznych resuscytacji.
Metody: W okresie od października do grudnia 2010 r. przeprowadzono telefoniczną ankietę mającą na celu ocenę, ile OAIT 
w Polsce stosuje TH jako terapię u pacjentów pozostających w stanie śpiączki po zatrzymaniu krążenia. Pozostałe zagadnienia 
ujęte w ankiecie dotyczyły: liczby schłodzonych pacjentów, stosowanej metody schładzania, temperatury docelowej, czasu 
stosowania TH i mechanizmu zatrzymania krążenia. Zbierano również dane dotyczące przedszpitalnego zastosowania TH 
i identyfikacji potencjalnych barier dla implementacji TH. 
Wyniki: Informację zwrotną uzyskano z 263 OAIT spośród 464 polskich OAIT (56,8%). Spośród nich 57 (21,7%) stosuje TH 
jako postępowanie wdrożone u pacjentów z przywróconym krążeniem. Większość ośrodków nie używa specjalistycznego 
sprzętu do indukcji czy podtrzymania hipotermii; 96% ośrodków (55 OAIT) stosujących TH robi to niezależnie od mechanizmu 
zatrzymania krążenia; 65% ośrodków (37 OAIT) stosuje docelowo temperaturę 32–34°C, a 63% (36 OAIT) utrzymuje hipotermię 
przez 12–24 godzin. Rośnie doświadczenie ośrodków: 61% z nich (35 OAIT) deklaruje zastosowanie TH w ciągu ostatniego 
roku u ponad 10 pacjentów. Stwierdzono istotne bariery w implementacji TH — brak rozpowszechnienia wiedzy dotyczącej 
wytycznych, brak lokalnych protokołów, brak sprzętu do prowadzenia TH i problemy z finansowaniem tego rodzaju terapii.
Wnioski: W latach 2005–2010 3-krotnie wzrosła liczba OAIT stosujących TH (7,6% vs. 21,7%), ale jest to wciąż niski odsetek 
w porównaniu z innymi krajami europejskimi. Dalsze prace powinny być ukierunkowane na zwalczanie barier w implemen-
tacji wytycznych resuscytacji.
Słowa kluczowe: hipotermia terapeutyczna, bariery, implementacja, resuscytacja, opieka poresuscytacyjna,  
syndrom poresuscytacyjny
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